NAD+ for Cognitive Energy & Fatigue: What the Evidence Shows

"Cognitive energy" is the promise underneath almost every NAD+ product — the idea that topping up a key cellular coenzyme will lift the heavy, drained, can't-think feeling that fatigue brings. The mechanism is genuinely appealing, and NAD+ really is central to how cells make energy. But the honest headline is the same one that runs through everything on this site: a reliable effect on a biomarker is not the same as a proven effect on how you feel or think. In the best-controlled human trials, NAD+ precursors raise NAD+ several-fold and still do not beat placebo for fatigue or cognition. This page separates the mechanism from the human results, and points first at the things that actually move fatigue.

"Mental energy" is a feeling, not a lab value

Before any supplement, it's worth being precise about what "low cognitive energy" usually is. Persistent tiredness and a foggy, effortful mind are non-specific symptoms — they sit on top of other causes rather than signalling a single missing molecule. The most reliable driver is sleep: reviews of sleep deprivation document clear, dose-dependent declines in attention, working memory, and processing speed⁶, and for many people "no mental energy" is simply accumulated sleep debt. Other common, very treatable drivers include thyroid dysfunction, which independently affects mood and cognition¹¹; vitamin B12 deficiency, a classic and reversible cause of fatigue and cognitive slowing¹²; post-viral illness such as long-COVID, which produces measurable cognitive impairment⁷; plus stress, low mood, and medication side effects.

This matters because none of the NAD+ evidence below outperforms finding and fixing the actual cause. We rule those causes in, one at a time, in What Actually Causes Brain Fog? — and that step comes before any product decision.

The mechanism: real, but a starting point not a result

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme at the center of cellular energy metabolism — it shuttles electrons through the reactions that turn food into ATP, and it's a substrate for repair and signalling enzymes. Tissue NAD+ tends to fall with age and metabolic stress, which is the entire premise of the "refuel your cells" pitch. Precursors such as NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are absorbed and reliably raise NAD+ in blood and tissue⁸. So far, so good: the biochemistry is real and the biomarker genuinely moves. For the precursor-by-precursor brain evidence — and why the positive cognitive trials used multi-ingredient cocktails, not NMN or NR alone — see NMN & NR for Brain Health.

The problem is the leap from there to "more mental energy." A mechanism tells you something is plausible; only a trial measuring fatigue or cognition tells you whether it works. On that test, the NAD+ story gets much weaker.

The fatigue trials: biomarker up, fatigue unchanged

The most directly relevant study is a 2025 randomized, placebo-controlled trial of nicotinamide riboside in people with long-COVID — a population defined partly by fatigue and "brain fog." NR at 2,000 mg/day raised NAD+ 2.6- to 3.1-fold, exactly as advertised at the biomarker level. But on the outcomes that matter, there were no significant differences versus placebo in cognition, and none in fatigue severity (p = 0.59), sleep quality, or mood¹. The cells were refuelled on paper; the tiredness didn't lift. (A small within-group, exploratory signal appeared after pooling groups, which the authors themselves flag as hypothesis-generating, not proof — and it's why this needs larger trials, not a marketing claim.)

That mirrors the broader cognition picture. In a randomized placebo-controlled trial of NR in older adults with mild cognitive impairment, oral NR again raised NAD+ but produced no cognitive improvement versus placebo⁵. Two well-controlled trials, two different fatigued/foggy populations, same result: the marker moves, the experience doesn't.

The "physical energy" angle is also thin

Because cognitive energy and physical energy get marketed together, it's worth checking the body side too. A 2022 randomized, double-blind trial of NMN (250 mg/day for 12 weeks) in older Japanese adults found a modest benefit: afternoon dosing nudged a lower-limb performance test and reduced self-reported drowsiness, with small effect sizes and no consistent improvement in overall fatigue or other performance measures². It's a real but minor, time-of-day-dependent signal on a drowsiness subscale — not evidence of restored "energy."

Zoom out and even that fades. A 2025 systematic review and meta-analysis of NMN and NR randomized trials concluded that current evidence does not support either precursor for preserving muscle mass or physical function in adults over 60 — no significant effect on grip strength, gait speed, or sit-to-stand performance³. So the physical-energy case isn't stronger than the cognitive one; pooled across trials, it's largely null.

The one place a "NAD-adjacent" supplement has shown a fatigue signal is a combination product. A randomized trial in myalgic encephalomyelitis/chronic fatigue syndrome found that CoQ10 plus NADH reduced perceived cognitive fatigue and improved quality of life within the treatment group⁴. Worth knowing — but read it honestly: it's NADH combined with CoQ10 (not the NAD+ precursors sold for "mental energy"), the strongest results are within-group rather than clean between-group effects, and the trial was industry-funded. It hints that mitochondrial-support combinations deserve study in genuine fatigue conditions; it does not validate a bottle of NMN for everyday tiredness.

A systematic review of NAD across clinical conditions reaches the sober summary: NAD-based interventions are generally well tolerated, but the evidence for benefit is inconsistent and the strongest claims outrun the data⁹. We keep that same discipline in our pillar overview, Does NAD+ Help Brain Fog? An Evidence Check, and in NAD+, Brain Fog & Focus: What the Evidence Shows.

Routes don't rescue the claim

A predictable response is that pills are the problem — that nasal sprays or IV drips would deliver the "energy" the gut can't. They might raise NAD+ differently, but there is no rigorous randomized trial of intranasal or intravenous NAD+ for fatigue or cognitive energy that shows a benefit oral precursors lack. The route changes the marketing, not the evidence; we examine the delivery question in Nasal NAD+ for Focus: Is There Evidence? and the clinic-drip version in NAD+ IV for Mental Clarity: Is It Worth It?. For long-COVID specifically — where mitochondrial "energy" claims are loudest — see NAD+ for Long-COVID Brain Fog.

What actually moves fatigue and mental energy

The evidence-first order of operations isn't on a supplement shelf:

• •Protect sleep first. It's the single best-supported lever for attention, processing speed, and the subjective sense of mental energy⁶. (When sleep loss is unavoidable, creatine has better evidence than NAD+ as a brain-energy buffer under that specific stress — see creatine for brain fog.)
• •Rule in a treatable cause. Thyroid dysfunction¹¹ and B12 deficiency¹² are common, reversible, and routinely missed; long-COVID and medication effects matter too⁷. So is obstructive sleep apnea — a strikingly common, underdiagnosed driver of daytime fatigue and fog that no precursor can touch, covered in sleep apnea and brain fog. Correcting a real deficiency or condition beats any "NAD boost."
• •Set honest expectations for consumables. Of the options people actually take, omega-3 has the most credible (still modest) general-cognition evidence in people without dementia¹⁰ — and that's a small effect, not a transformation. NAD+ precursors raise the biomarker and have a clean safety record⁹, but haven't beaten placebo for fatigue or cognition¹⁵.

The bottom line

NAD+ for cognitive energy and fatigue is a textbook case of a strong mechanism running ahead of weak human results. Precursors like NR and NMN are real molecules that reliably raise NAD+ — but in the best randomized trials, that biomarker rise did not translate into less fatigue, more mental energy, or better cognition versus placebo. The physical-performance case is similarly thin to null, and only a CoQ10-plus-NADH combination has shown a fatigue signal, in industry-funded ME/CFS research, on within-group measures. If you're chasing mental energy, the highest-yield moves are unglamorous: protect your sleep, and rule in causes like thyroid problems, B12 deficiency, or post-viral fatigue before reaching for a precursor. If low mood or chronic stress is part of the tiredness, see how that connects in NAD+, Stress & Mood: What's the Real Link?. If you still want to weigh cognitive-energy products against that evidence bar, see our best cognitive-energy picks and how NAD+ stacks up against the alternatives in NAD+ vs Nootropics for Focus.